XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.4
Note 3 - Stock-based Compensation
 9 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

3. Stock-Based Compensation

 

The Company accounts for its stock-based compensation at fair value. The following table summarizes stock-based compensation expense by financial statement line item for the three and nine months ended  December 31, 2023 and 2022 (in thousands):

 

  

Three Months Ended December 31,

  

Nine Months Ended December 31,

 
  

2023

  

2022

  

2023

  

2022

 

Cost of revenues

 $62  $89  $230  $195 

Research and development

  158   214   469   570 

Selling, general and administrative

  920   1,137   2,909   2,727 

Total

 $1,140  $1,440  $3,608  $3,492 

  

The Company issued no shares and 681,500 shares of restricted stock during the three and nine months ended December 31, 2023, respectively. The Company issued no shares of immediately vested common stock during the three months ended December 31, 2023 and 53,675 shares of immediately vested common stock during the nine months ended December 31, 2023. The Company issued 550,000 shares of restricted stock and no shares of immediately vested common stock during the three months ended  December 31, 2022 and 888,500 shares of restricted stock and 25,806 shares of immediately vested common stock during the nine months ended December 31, 2022. These restricted stock awards generally vest over 2-3 years. Awards for restricted stock include both time-based and performance-based awards. For options and restricted stock awards that vest upon the passage of time, expense is being recorded over the vesting period. Performance-based awards are expensed over the requisite service period based on probability of achievement.

 

The estimated fair value of the Company’s stock-based awards, less expected annual forfeitures, is amortized over the awards’ service period. The total unrecognized compensation cost for unvested stock options was less than $0.1 million as of December 31, 2023. This expense will be recognized over a weighted average of approximately 0.4 years. The total unrecognized compensation cost for unvested outstanding restricted stock was $5.8 million as of  December 31, 2023. This expense will be recognized over a weighted-average expense period of approximately 1.7 years.

 

The Company granted no stock options during the three and nine months ended  December 31, 2023. The Company granted no stock options in the three months ended  December 31, 2022, and 20,564 stock options during the nine months ended  December 31, 2022. The stock options granted during the nine months ended December 31, 2022 will vest in equal annual installments over 2 years. The weighted average assumptions used in the Black Scholes valuation model for stock options granted during the nine months ended December 31, 2022 are as follows:

 

Expected volatility

  71.40%

Risk-free interest rate

  3.10%

Expected life (years)

  6.14 

Dividend yield

 

None